Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Nature study: A novel family of antibiotics against tuberculosis and salmonella target pathways active in cancer.

29.11.2007
Researchers have discovered new ways to fight bacterial infections including extensively drug-resistant tuberculosis. The work will be published in the journal Nature on 29 November.

The research led by Dr. Jacques Neefjes from the Netherlands Cancer Institute, with collaboration of Dr. Tom Ottenhoff from the Leiden University Medical Center and Dr. Hermen Overkleeft from the Leiden University Institute of Chemistry, shows that pathways commonly found in cancer cells are also modified by pathogenic bacteria. It is likely that the discovery will lead to new drugs against cancer and tuberculosis.

The Dutch groups have developed chemical compounds which can greatly reduce the bacterial loads within infected human cells (such as Mycobacteria tuberculosis and Salmonella typhimurium). The chemical compounds they generated inhibit PKB/Akt1 enzymes in cells, enzymes which are also upregulated in various cancers. It appears that pathogenic bacteria seize control of PKB/Akt1 to evade immune degradation. Inhibiting the PKB/Akt1 enzyme thus forces the bacteria back into the degradation pathway to be eliminated.

PKB/Akt1 is the focus of cancer research at present since it has been shown to stimulate the growth of cancer cells. Discovering that bacteria utilize PKB/Akt1 in order to survive, sheds some light onto mechanisms that lead to cancer development following chronic bacterial infections in some patients.

“Many anti-cancer drugs originate from antibiotic discovery attempts. Pharmaceutical companies are currently developing specific PKB/Akt1 inhibitors. It is feasible that these inhibitors may well work against bacterial infections also”, says Dr. Jacques Neefjes.

This month, the World Health Organization (WHO) sounded the alarm because of a severe increase in multi and extensively drug-resistant (MDR and XDR) Mycobacterium tuberculosis infected countries. For MDR and XDR infected patients, current antibiotic therapy is inefficient or ineffective. New antibiotic therapies are therefore urgently needed.

This research was supported by the Netherlands Organization for Scientific Research (NWO), the Dutch Cancer Society (KWF) and an EEC network grant.

Frederique Melman | alfa
Further information:
http://www.nki.nl/Research/

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>